191 results on '"Sawicki, Grzegorz"'
Search Results
2. Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity – A systematic review
3. In Vivo Study on Doxycycline Protective Mechanisms during Myocardial Ischemia Injury in Rats.
4. Pre-arrest doxycycline protects donation after circulatory death kidneys
5. Protection of the transplant kidney during cold perfusion with doxycycline: proteomic analysis in a rat model
6. Mitoquinone Alleviates Donation after Cardiac Death Kidney Injury during Hypothermic Machine Perfusion in Rat Model.
7. Inhibition of MMP-2 expression affects metabolic enzyme expression levels: Proteomic analysis of rat cardiomyocytes
8. Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia–reperfusion injury
9. An infection of human adenovirus 31 affects the differentiation of preadipocytes into fat cells, its metabolic profile and fat accumulation
10. Adenovirus type 9 enhances differentiation and decreases cytokine release from preadipocytes
11. Proteomics analysis of changes in myocardial proteins during endotoxemia
12. Proteomic analysis of cardiac metabolic enzymes in asphyxiated newborn piglets
13. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion
14. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors
15. AT1receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: Detection using proteomics
16. Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart
17. Synergistic protection of MLC 1 against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future
18. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2
19. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia–reperfusion injury
20. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction
21. Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion
22. Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2
23. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
24. Serum levels of matrix metalloproteinase-2 and −9 and conventional tumor markers (CEA and CA 19—9) in patients with colorectal and gastric cancers
25. Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione
26. Pharmacological Protection of Kidney Grafts from Cold Perfusion-Induced Injury
27. Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade
28. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts
29. Activity of serum matrix metalloproteinase 9 in patients with obstructive sleep apnea.
30. Novel O-palmitolylated beta-E1 subunit of pyruvate dehydrogenase is phosphorylated during ischemia/reperfusion injury
31. Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury
32. Release of gelatinase A during platelet activation mediates aggregation
33. Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury.
34. Cardioprotective effect of MMP‐2‐inhibitor‐NO‐donor hybrid against ischaemia/reperfusion injury.
35. Biocompatible Carbon-Based Coating as Potential Endovascular Material for Stent Surface.
36. Intracellular Regulation of Matrix Metalloproteinase-2 Activity: New Strategies in Treatment and Protection of Heart Subjected to Oxidative Stress
37. Low frequency electromagnetic field decreases ischemia–reperfusion injury of human cardiomyocytes and supports their metabolic function.
38. Early experience with hypothermic machine perfusion of living donor kidneys - a retrospective study.
39. Proteomic Analysis of Perfusate from Machine Cold Perfusion of Transplant Kidneys: Insights Into Protection from Injury.
40. Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.
41. Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/ MLCK-mediated cardiomyocyte protection from hypoxic injury.
42. Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart.
43. Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity.
44. Synergistic protection of MLC I against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future.
45. Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/reperfusion.
46. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemiaereperfusion injury.
47. Effect of the Rho kinase inhibitor Y-27632 on the proteome of hearts with ischemia-reperfusion injury.
48. Neonatal Asphyxia Induces the Nitration of Cardiac Myosin Light Chain 2 That is Associated with Cardiac Systolic Dysfunction.
49. Novel O-palmitolylated beta-E1 subunit ofpyruvate dehydrogenase is phosphorylated duringischemia/reperfusion injury.
50. Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.